104 related articles for article (PubMed ID: 15893376)
1. Antidepressant effects assessed using behavior maintained under a differential-reinforcement-of-low-rate (DRL) operant schedule.
O'Donnell JM; Marek GJ; Seiden LS
Neurosci Biobehav Rev; 2005; 29(4-5):785-98. PubMed ID: 15893376
[TBL] [Abstract][Full Text] [Related]
2. Differential reinforcement of low rates differentially decreased timing precision.
Eckard ML; Kyonka EGE
Behav Processes; 2018 Jun; 151():111-118. PubMed ID: 29608943
[TBL] [Abstract][Full Text] [Related]
3. Order in the absence of an effect: Identifying rate-dependent relationships.
Snider SE; Quisenberry AJ; Bickel WK
Behav Processes; 2016 Jun; 127():18-24. PubMed ID: 27001350
[TBL] [Abstract][Full Text] [Related]
4. Antidepressant and Antipsychotic Drugs.
Krystal AD
Sleep Med Clin; 2010 Dec; 5(4):571-589. PubMed ID: 21499530
[No Abstract] [Full Text] [Related]
5. Interval timing relative to response inhibition in the differential reinforcement of low-rate responding in normally developing young adults.
Yang TH; Liao RM; Su CI; Chien CY; Ng CT; Yen NS
Sci Rep; 2023 Jul; 13(1):11977. PubMed ID: 37488262
[TBL] [Abstract][Full Text] [Related]
6. Ropanicant (SUVN-911), an α4β2 nicotinic acetylcholine receptor antagonist intended for the treatment of depressive disorders: pharmacological, behavioral, and neurochemical characterization.
Nirogi R; Abraham R; Jayarajan P; Goura V; Kallepalli R; Medapati RB; Tadiparthi J; Goyal VK; Pandey SK; Subramanian R; Petlu S; Thentu JB; Palacharla VRC; Gagginapally SR; Mohammed AR; Jasti V
Psychopharmacology (Berl); 2022 Jul; 239(7):2215-2232. PubMed ID: 35298691
[TBL] [Abstract][Full Text] [Related]
7. Comparative effects of cannabinoid CB1 receptor agonist and antagonist on timing impulsivity induced by d-amphetamine in a differential reinforcement of low-rate response task in male rats.
Chen SF; Hsu WC; Lu XY; Chuang CY; Liao RM
Psychopharmacology (Berl); 2022 May; 239(5):1459-1473. PubMed ID: 34741633
[TBL] [Abstract][Full Text] [Related]
8. Extending the Specificity of DRL 72-s Behavior for Screening Antidepressant-Like Effects of Glutamatergic Clinically Validated Anxiolytic or Antidepressant Drugs in Rats.
Marek GJ; Salek AA
J Pharmacol Exp Ther; 2020 Jul; 374(1):200-210. PubMed ID: 32265323
[TBL] [Abstract][Full Text] [Related]
9. The selective GSK3 inhibitor, SAR502250, displays neuroprotective activity and attenuates behavioral impairments in models of neuropsychiatric symptoms of Alzheimer's disease in rodents.
Griebel G; Stemmelin J; Lopez-Grancha M; Boulay D; Boquet G; Slowinski F; Pichat P; Beeské S; Tanaka S; Mori A; Fujimura M; Eguchi J
Sci Rep; 2019 Dec; 9(1):18045. PubMed ID: 31792284
[TBL] [Abstract][Full Text] [Related]
10. Atomoxetine improves memory and other components of executive function in young-adult rats and aged rhesus monkeys.
Callahan PM; Plagenhoef MR; Blake DT; Terry AV
Neuropharmacology; 2019 Sep; 155():65-75. PubMed ID: 31108108
[TBL] [Abstract][Full Text] [Related]
11. 5-HT1a Receptor Involvement in Temporal Memory and the Response to Temporal Ambiguity.
Shapiro ZR; Cerasiello S; Hartshorne L; Matell MS
Front Neurosci; 2018; 12():439. PubMed ID: 30018532
[TBL] [Abstract][Full Text] [Related]
12. Developmental exposure to low level ambient ultrafine particle air pollution and cognitive dysfunction.
Cory-Slechta DA; Allen JL; Conrad K; Marvin E; Sobolewski M
Neurotoxicology; 2018 Dec; 69():217-231. PubMed ID: 29247674
[TBL] [Abstract][Full Text] [Related]
13. κ-Opioid Receptor Activation in Dopamine Neurons Disrupts Behavioral Inhibition.
Abraham AD; Fontaine HM; Song AJ; Andrews MM; Baird MA; Kieffer BL; Land BB; Chavkin C
Neuropsychopharmacology; 2018 Jan; 43(2):362-372. PubMed ID: 28649993
[TBL] [Abstract][Full Text] [Related]
14. Rodent models of treatment-resistant depression.
Caldarone BJ; Zachariou V; King SL
Eur J Pharmacol; 2015 Apr; 753():51-65. PubMed ID: 25460020
[TBL] [Abstract][Full Text] [Related]
15. Comparison of antidepressant-like and abuse-related effects of phencyclidine in rats.
Hillhouse TM; Porter JH; Negus SS
Drug Dev Res; 2014 Dec; 75(8):479-88. PubMed ID: 25315690
[TBL] [Abstract][Full Text] [Related]
16. Dissecting impulsivity and its relationships to drug addictions.
Jentsch JD; Ashenhurst JR; Cervantes MC; Groman SM; James AS; Pennington ZT
Ann N Y Acad Sci; 2014 Oct; 1327():1-26. PubMed ID: 24654857
[TBL] [Abstract][Full Text] [Related]
17. LSN2424100: a novel, potent orexin-2 receptor antagonist with selectivity over orexin-1 receptors and activity in an animal model predictive of antidepressant-like efficacy.
Fitch TE; Benvenga MJ; Jesudason CD; Zink C; Vandergriff AB; Menezes MM; Schober DA; Rorick-Kehn LM
Front Neurosci; 2014; 8():5. PubMed ID: 24478625
[TBL] [Abstract][Full Text] [Related]
18. The effects of clinically relevant doses of amphetamine and methylphenidate on signal detection and DRL in rats.
Andrzejewski ME; Spencer RC; Harris RL; Feit EC; McKee BL; Berridge CW
Neuropharmacology; 2014 Apr; 79():634-41. PubMed ID: 24467844
[TBL] [Abstract][Full Text] [Related]
19. Effects of 5-hydroxytryptamine 2C receptor agonist MK212 and 2A receptor antagonist MDL100907 on maternal behavior in postpartum female rats.
Chen W; Zhang Q; Su W; Zhang H; Yang Y; Qiao J; Sui N; Li M
Pharmacol Biochem Behav; 2014 Feb; 117():25-33. PubMed ID: 24321440
[TBL] [Abstract][Full Text] [Related]
20. Simultaneous blockade of dopamine and noradrenaline reuptake promotes disadvantageous decision making in a rat gambling task.
Baarendse PJ; Winstanley CA; Vanderschuren LJ
Psychopharmacology (Berl); 2013 Feb; 225(3):719-31. PubMed ID: 22968659
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
